Skip to main content
. 2022 Nov 17;15:84. doi: 10.1186/s40545-022-00490-4

Table 3.

Infections and non-infectious comorbidities among hospitalized adult patients in JMC wards during the study period (n = 360)

Comorbidities and risk status indicators Wards of JMC Total, N (%)
Medical, N (%) Surgical (%) GYN/OBS (N)
Presentence of comorbidities
 No 16 (4.4) 81 (22.5) 67 (18.6) 164 (45.6)
 Yes 136 (37.8) 25 (6.9) 35 (9.7) 196 (54.4)
 Total 152 (42.2) 106 (29.5) 102 (28.3) 360 (100)
Infections and non-infectious comorbidities*
 Hypertension 23 (11.7) 7 (3.6) 8 (4.1) 38 (19.4)
 Heart failure 29 (14.8) 1 (0.5) 5 (2.6) 35 (17.9)
 Diabetes mellitus 15 (7.7) 2 (1.0) 3 (1.5) 20 (10.2)
 Acute/chronic kidney diseases 25 (12.8) 1 (0.5) 0 (0.0) 26 (13.3)
 Moderate/severe liver diseases 10 (5.1) 0 (0.0) 0 (0.0) 10 (5.1)
 Neurologic diseases 4 (2%) 3 (1.5) 1 (0.5) 8 (4.1%)
 Tuberculosis 34 (17.3) 3 (1.5) 0 (0.0) 37 (18.9)
 HIV/AIDS 15 (7.7) 0 (0.0) 2 (1.0) 17 (8.7)
 Metastatic solid tumor 8 (4.1) 6 (3.1) 10 (5.1) 24 (12.2)
 Other malignancies** 9 (4.6) 1 (0.5) 4 (2.0) 14 (7.1)
 Asthma and COPD 16 (8.2) 4 (2%) 6 (3.1) 26 (13.3)
 Neurologic diseases 4 (2%) 3 (1.5) 1 (0.5) 8 (4.1%)
 Anemia of chronic diseases 6 (3.1) 4 (2%) 0 (0.0) 10 (5.1)
 Malaria 3 (1.5) 0 (0.0) 0 (0.0) 3 (1.5)
 Esophageal candidiasis 1 (0.5) 1 (0.5) 0 (0.0) 2 (1.0)

*A given patient may have > 1 comorbidities

**Hematological malignancies and non-metastatic solid tumor